Literature DB >> 12875679

A survey of blindness and poor vision in leprosy patients.

Liangbin Yan1, Guocheng Zhang, Zhiju Zheng, Wenzhong Li, Ganyun Ye.   

Abstract

OBJECTIVE: To determine the prevalence, cause and distributions of blindness and poor vision in patients with leprosy.
METHODS: An epidemiological survey of blindness and poor vision among 1045 cases of leprosy was carried out in Taixing City of Jiangsu Province, China.
RESULTS: The prevalence of bilateral blindness was 7.67%, unilateral blindness 4.4%, bilateral poor vision of various degrees 9.28% and unilateral poor vision 5.84%. The prevalence of eye complications varied significantly among different groups of patients; females had a higher prevalence than males, multibacillary patients higher than paucibacillary patients, and in-patients higher than out-patients. Corneal disease was the most common cause of blindness in study groups, followed by iritic disease and cataract; while the main cause of poor vision was cataract, then corneal and iritic diseases. Treatable blindness accounted for 62.7% of the cases and treatable poor vision for 88.6% of the patients studied. 56.62% of cases with eye complications expressed their willingness to be treated.
CONCLUSIONS: Although prevention and treatment of low vision and blindness in leprosy patients is very hard, it is necessary for doctors and medical workers to make clear of the factors to cause low vision and blindness, especially those in leprosy patients so that some measures for prevention and treatment of the disease could be taken accordingly.

Entities:  

Mesh:

Year:  2003        PMID: 12875679

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  1 in total

1.  Prevalence and etiologies of visual handicaps in leprosy patients in the south of Cameroon.

Authors:  André Omgbwa Eballé; Didier Owono; Alphonse Um Book; Assumpta Lucienne Bella; Come Ebana Mvogo; Nsom Mba
Journal:  Clin Ophthalmol       Date:  2009-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.